Who owns Charles River Laboratories International (CRL)? Superinvestor holders
7 superinvestors of the 157 tracked here hold Charles River Laboratories International (CRL) in their latest 13F filing, with $1.3B between them. John Rogers gives it the most weight: 3.66% of the reported portfolio. In their latest reported quarter, Bill Nygren, Karthik Sarma and Joel Greenblatt added; John Rogers, Anthony Bozza, Ken Griffin and Murray Stahl reduced.
Lee Ainslie sold out of it in their latest quarter.
Key facts
- Superinvestors holding it
- 7 of 157
- Biggest holder
- Bill Nygren, $508.3M
- Largest weight
- John Rogers, 3.66%of their portfolio
- Combined value
- $1.3B
- Bought last quarter
- 3
- Sold last quarter
- 5
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | John RogersAriel Investments | 3.66% | $352M | 1.19M | ▼ Reduced 21% | −312.83K | Q3 2026 |
| 2 | Anthony BozzaLakewood Capital | 0.90% | $16.7M | 56.75K | ▼ Reduced 58% | −77.25K | Q3 2026 |
| 3 | Bill NygrenHarris Associates (Oakmark) | 0.68% | $508.3M | 2.24M | ▲ Added 4.1% | +87.85K | Q2 2026 |
| 4 | Karthik SarmaSRS Investment Management | 0.54% | $57.3M | 194.33K | ▲ Added 3.7% | +6.95K | Q3 2026 |
| 5 | Joel GreenblattGotham Asset Management | 0.23% | $98.2M | 433.15K | ▲ Added 21% | +74.64K | Q2 2026 |
| 6 | Ken GriffinCitadel Advisors | 0.16% | $270.7M | 1.19M | ▼ Reduced 1.5% | −18.55K | Q2 2026 |
| 7 | Murray StahlHorizon Kinetics | 0.02% | $1.9M | 6.44K | ▼ Reduced 9.3% | −659 | Q3 2026 |
Sold out last quarter
- Lee Ainsliewas $1.4M · Q2 2026
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 4 | 1.45M | $428M | 1 | 3 |
| Q2 2026 | 157 | 7 | 5.7M | $1.3B | 5 | 3 |
| Q1 2026 | 157 | 8 | 5.3M | $914.4M | 6 | 2 |
| Q4 2025 | 157 | 6 | 4.02M | $802.6M | 2 | 5 |
| Q3 2025 | 157 | 7 | 3.55M | $555.9M | 5 | 1 |
| Q2 2025 | 157 | 6 | 3.18M | $482.5M | 4 | 5 |
| Q1 2025 | 156 | 7 | 3.46M | $521M | 5 | 4 |
| Q4 2024 | 156 | 7 | 3.51M | $647M | 4 | 3 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| John Rogers | 1.19M | 1.51M | 1.44M | 1.43M | 1.49M | 1.42M | 1.1M | 1.07M |
| Karthik Sarma | 194.33K | 187.38K | — | — | — | — | — | — |
| Anthony Bozza | 56.75K | 134K | 69K | 140.24K | 140.24K | 140.24K | 140.24K | 111.74K |
| Murray Stahl | 6.44K | 7.1K | 12.19K | 12.58K | 12.91K | 22.26K | 34.29K | 59.84K |
| Bill Nygren | · | 2.24M | 2.15M | 1.68M | 1.47M | 1.16M | — | — |
| Ken Griffin | · | 1.19M | 1.21M | — | — | — | — | — |
| Joel Greenblatt | · | 433.15K | 358.5K | 289.52K | 315.76K | 269.16K | 154.78K | 123.69K |
| Louis Bacon | — | — | 43.23K | — | 48.93K | — | 41.93K | — |
| Lee Ainslie | · | — | 8.18K | — | — | — | — | — |
| Josef Lakonishok | — | — | — | 475.9K | — | — | — | — |
| Robert Pitts | · | — | — | — | 71.9K | — | — | — |
| Paul Tudor Jones | · | — | — | — | — | 169.79K | — | — |
| Lauren Taylor Wolfe | — | — | — | — | — | — | 1.21M | 1.2M |
| Daniel Sundheim | — | — | — | — | — | — | 777.49K | 935.82K |
| Polen Capital team | — | — | — | — | — | — | — | 4.25K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own CRL?
In their latest 13F filings: John Rogers (3.66% of the portfolio, $352M), Anthony Bozza (0.90% of the portfolio, $16.7M), Bill Nygren (0.68% of the portfolio, $508.3M), Karthik Sarma (0.54% of the portfolio, $57.3M), Joel Greenblatt (0.23% of the portfolio, $98.2M), Ken Griffin (0.16% of the portfolio, $270.7M), Murray Stahl (0.02% of the portfolio, $1.9M).
Who bought CRL last quarter?
Bill Nygren (added 4.1%), Karthik Sarma (added 3.7%), Joel Greenblatt (added 21%). “Last quarter” is each investor's latest reported quarter.
Who sold CRL last quarter?
Reduced: John Rogers (21% fewer shares), Anthony Bozza (58% fewer shares), Ken Griffin (1.5% fewer shares), Murray Stahl (9.3% fewer shares). Sold out entirely: Lee Ainslie (was $1.4M).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Charles River Laboratories International (CRL)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/CRL/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to CRL by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.